Indoramin

DB08950ApprovedWithdrawnSmall molecule

Indoramin is a discontinued piperidine antiadrenergic drug with the trade names Baratol and Doralese. It is a selective alpha-1 adrenergic antagonist with no reflex tachycardia and direct myocardial depression action.

Chemical structure of Indoramin
Formula / weight
C22H25N3O · 347.4534 g/mol (avg)
Also known as
Indoramina · Indoramine
Code names
WY-21901

Resolves to

Compound
UNII0Z802HMY7HCAS26844-12-2ChEMBLCHEMBL279516ChEBI135470PubChem33625KEGGD04531
Clinical / RWD
RxNorm5784ATCC02CA02
Structure
InChIKeyJXZZEXZZKAWDSP-UHFFFAOYSA-NSMILESO=C(NC1CCN(CCC2=CNC3=C2C=CC=C3)CC1)C1=CC=CC=C1
Targets
P18089ADRA2BP18825ADRA2CP25100ADRA1DP35348ADRA1A

What you can answer from here — as of September 13, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
708Drug interactionsStructured to mechanism, not free text
Sign in
3Marketed productsAcross 1 country and 2 labellers
Sign in
1ATC codeIncluding every combination product, plus 19 drug categories
Sign in
13+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Indoramin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In